BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22262505)

  • 1. Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis.
    Kwakkenbos L; van den Hoogen FH; Custers J; Prins J; Vonk MC; van Lankveld WG; Becker ES; van den Ende CH
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):930-4. PubMed ID: 22262505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fear of progression in partners of chronically ill patients.
    Zimmermann T; Herschbach P; Wessarges M; Heinrichs N
    Behav Med; 2011 Jul; 37(3):95-104. PubMed ID: 21895427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire.
    Herschbach P; Berg P; Dankert A; Duran G; Engst-Hastreiter U; Waadt S; Keller M; Ukat R; Henrich G
    J Psychosom Res; 2005 Jun; 58(6):505-11. PubMed ID: 16125517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem.
    Kwakkenbos L; van Lankveld WG; Vonk MC; Becker ES; van den Hoogen FH; van den Ende CH
    J Psychosom Res; 2012 Mar; 72(3):199-204. PubMed ID: 22325699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study.
    Wu Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Sun Y; Bhandari PM; Carboni-Jiménez A; Gagarine M; He C; Krishnan A; Negeri ZF; Neupane D; Mouthon L; Bartlett SJ; Benedetti A; Thombs BD; ;
    J Psychosom Res; 2020 Dec; 139():110271. PubMed ID: 33096402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the chronic venous insufficiency quality of life questionnaire in Dutch patients treated for varicose veins.
    Biemans AA; van der Velden SK; Bruijninckx CM; Buth J; Nijsten T
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):246-53. PubMed ID: 21531589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fear of movement in cancer survivors: validation of the modified Tampa scale of kinesiophobia-fatigue.
    Velthuis MJ; Van den Bussche E; May AM; Gijsen BC; Nijs S; Vlaeyen JW
    Psychooncology; 2012 Jul; 21(7):762-70. PubMed ID: 21538679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.
    Hudson M; Steele R; Taillefer S; Baron M;
    Arthritis Rheum; 2008 Feb; 59(2):270-8. PubMed ID: 18240187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
    Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
    J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
    Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis.
    Thombs BD; Hudson M; Schieir O; Taillefer SS; Baron M;
    Arthritis Rheum; 2008 Mar; 59(3):438-43. PubMed ID: 18311754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric testing confirms that the Brazilian-Portuguese adaptations, the original versions of the Fear-Avoidance Beliefs Questionnaire, and the Tampa Scale of Kinesiophobia have similar measurement properties.
    de Souza FS; Marinho Cda S; Siqueira FB; Maher CG; Costa LO
    Spine (Phila Pa 1976); 2008 Apr; 33(9):1028-33. PubMed ID: 18427325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease.
    Hudson M; Bernatsky S; Taillefer S; Fortin PR; Wither J; Baron M; ;
    J Clin Epidemiol; 2008 Jul; 61(7):654-62. PubMed ID: 18342489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Fear-Avoidance Beliefs Questionnaire in patients with neck pain.
    Lee KC; Chiu TT; Lam TH
    Clin Rehabil; 2006 Oct; 20(10):909-20. PubMed ID: 17008342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring pain in systemic sclerosis: comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain.
    El-Baalbaki G; Lober J; Hudson M; Baron M; Thombs BD;
    J Rheumatol; 2011 Dec; 38(12):2581-7. PubMed ID: 21965643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neck Bournemouth Questionnaire cross-cultural adaptation into Dutch and evaluation of its psychometric properties in a population with subacute and chronic whiplash associated disorders.
    Schmitt MA; de Wijer A; van Genderen FR; van der Graaf Y; Helders PJ; van Meeteren NL
    Spine (Phila Pa 1976); 2009 Nov; 34(23):2551-61. PubMed ID: 19927105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a manual ability questionnaire in patients with systemic sclerosis.
    Vanthuyne M; Smith V; Arat S; Westhovens R; de Keyser F; Houssiau FA; Thonnard JL; Vandervelde L
    Arthritis Rheum; 2009 May; 61(5):695-703. PubMed ID: 19405012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fear of progression in cancer patients with recurrence.
    Shim EJ; Shin YW; Oh DY; Hahm BJ
    Gen Hosp Psychiatry; 2010; 32(2):169-75. PubMed ID: 20302991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.